Science Pipeline People Patients Let science lead the way ; ©2020 Omeros Corporation, All rights reserved. Site Map Contact Us Privacy Policy Legal We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. If you continue to browse this site, you will accept our use of cookies. For more information, please read our Privacy Policy. AGREE

Skip to main navigation Investor Relations Press Releases Events Governance Financial Information Stock Information FAQs Contact Us Investor Relations Home CORPORATE PROFILE Here you will find financial reports and shareholder information about Omeros Corporation, including recent news, current and historical share price, and electronic copies of our SEC filings. STOCK QUOTE OMER (Common Stock) Exchange NASDAQ (US Dollar) Price $7.63 Change (%) +0.13 (+1.73%) Volume 370,079 Data as of 11/23/21 3:34 PM EST Data Provided by Refinitiv. Minimum 15 minutes delayed. MORE RECENT PRESS RELEASES Date Title and Summary Nov 09, 2021 Omeros Corporation Reports Third Quarter 2021 Financial Results Nov 05, 2021 Omeros Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial Nov 05, 2021 Omeros’ Narsoplimab Stabilized Kidney Function and Reduced Urinary Complement Proteins in a Patient with IgA Vasculitis Nov 04, 2021 Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2021 MORE UPCOMING EVENTS There are currently no events to display. MORE FEATURED REPORTS ASN 2021: Reduction of Urinary Levels of Lectin Pathway Complement Components in an IgA Vasculitis Patient After MASP-2 Inhibition with Narsoplimab ASN 2021: Long-Term Phase 2 Efficacy of the MASP-2 Inhibitor Narsoplimab for the Treatment of Severe IgA Nephropathy RECEIVE E-MAIL ALERTS Sign up to receive e-mail alerts whenever Omeros Corporation posts new information to the site. Just enter your e-mail address and click Submit. Required fields denoted by an asterisk (). Alert type Omeros Corporation SEC Filings Alert Omeros Corporation Event Alert Omeros Corporation Press Release Alert Email ©2021 Omeros Corporation, All rights reserved. Site Map Contact Us Privacy Policy Legal We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. If you continue to browse this site, you will accept our use of cookies. For more information, please read our Privacy Policy. AGREE